Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Gracell Biotechnologies (GRCL)
NASDAQ:GRCL
RESEARCH TOOLSreports
Gracell Biotechnologies (GRCL) Stock Forecast & Price Target
134 Followers
See the Price Targets and Ratings of:
GRCL Analyst Ratings
Hold
1 Buy
6 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
GRCL Stock 12 Month Forecast
Average Price Target
$10.35
▲(0.98% Upside)
| Highest Price Target$11.50 | Average Price Target$10.35 | Lowest Price Target$10.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Stifel Nicolaus
Downgraded
02/22/24
Piper Sandler
Downgraded
12/26/23
H.C. Wainwright
Downgraded
12/26/23
Cantor Fitzgerald
―
Buy
―
Initiated
11/09/23
Cantor Fitzgerald assumes Gracell Biotechnologies Inc (GRCL) at OverweightCantor Fitzgerald analyst Eric Schmidt assumes coverage on Gracell Biotechnologies Inc (NASDAQ: GRCL) with a Overweight rating.
Citi
$11.00
Buy
7.32%
Upside
Reiterated
08/29/23
Analysts Are Bullish on Top Healthcare Stocks: Gracell Biotechnologies (GRCL), Intellia Therapeutics (NTLA)
Barclays
$13.00
Buy
26.83%
Upside
Reiterated
08/14/23
Wall Street Analysts Are Bullish on Top Healthcare Picks
Best Analysts Covering Gracell Biotechnologies
Which Analyst Should I Follow If I Want to Buy GRCL and Sell After:
1 Month
3 Months
1 Year
Success Rate
2/2 ratings generated profit
Average Return
+273.35%
reiterated a buy rating 8 months ago
Copying Yigal Nochomovitz's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +273.35% per trade.
2 Years
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
GRCL Analyst Recommendation Trends
Rating
Aug 23
Sep 23
Oct 23
Nov 23
Dec 23
Strong Buy
12
11
8
8
7
Buy
0
0
0
3
4
Hold
0
0
0
0
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
12
11
8
11
16
Each month's total comprises the sum of three months' worth of ratings.
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
GRCL Financial Forecast
GRCL Stock Forecast FAQ
What is GRCL’s average 12-month price target, according to analysts?
Based on analyst ratings, Gracell Biotechnologies’s 12-month average price target is $10.35.
What is GRCL’s upside potential, based on the analysts’ average price target?
Gracell Biotechnologies has 0.98% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is GRCL a Buy, Sell or Hold?
Gracell Biotechnologies has a conensus rating of Hold which is based on 1 buy ratings, 6 hold ratings and 0 sell ratings.
What is Gracell Biotechnologies’s price target?
The average price target for Gracell Biotechnologies is $10.35. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $11.50 ,the lowest forecast is $10.00. The average price target represents 0.98% Increase from the current price of $10.25.
The highest analyst price target is $11.50 ,the lowest forecast is $10.00. The average price target represents 0.98% Increase from the current price of $10.25.
What do analysts say about Gracell Biotechnologies?
Gracell Biotechnologies’s analyst rating consensus is a Hold. This is based on the ratings of 7 Wall Streets Analysts.
How can I buy shares of GRCL?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.